AAAAAA

   
Results: 1-11 |
Results: 11

Authors: Ahmed, RKS Nilsson, C Biberfeld, G Thorstensson, R
Citation: Rks. Ahmed et al., Role of CD8(+) cell-produced anti-viral factors in protective immunity in HIV-2-exposed but seronegative macaques resistant to intrarectal SIVsm challenge, SC J IMMUN, 53(3), 2001, pp. 245-253

Authors: Nilsson, C Makitalo, B Berglund, P Bex, F Liljestrom, P Sutter, G Erfle, V ten Haaft, P Heeney, J Biberfeld, G Thorstensson, R
Citation: C. Nilsson et al., Enhanced simian immunodeficiency virus-specific immune responses in macaques induced by priming with recombinant Semliki Forest virus and boosting with modified vaccinia virus Ankara, VACCINE, 19(25-26), 2001, pp. 3526-3536

Authors: Walther-Jallow, L Nilsson, C Soderlund, J ten Haaft, P Makitalo, B Biberfeld, P Bottiger, P Heeney, J Biberfeld, G Thorstensson, R
Citation: L. Walther-jallow et al., Cross-protection against mucosal simian immunodeficiency virus (SIVsm) challenge in human immunodeficiency virus type 2-vaccinated cynomolgus monkeys, J GEN VIROL, 82, 2001, pp. 1601-1612

Authors: Lindback, S Thorstensson, R Karlsson, AC von Sydow, M Flamholc, L Blaxhult, A Sonnerborg, A Biberfeld, G Gaines, H
Citation: S. Lindback et al., Diagnosis of primary HIV-1 infection and duration of follow-up after HIV exposure, AIDS, 14(15), 2000, pp. 2333-2339

Authors: Makitalo, B Bottiger, P Biberfeld, G Thorstensson, R
Citation: B. Makitalo et al., Cell-mediated immunity to low doses of SIVsm in cynomolgus macaques did not confer protection against mucosal rechallenge, VACCINE, 19(2-3), 2000, pp. 298-307

Authors: Brust, S Duttmann, H Feldner, J Gurtler, L Thorstensson, R Simon, F
Citation: S. Brust et al., Shortening of the diagnostic window with a new combined HIV p24 antigen and anti-HIV-1/2/O screening test, J VIROL MET, 90(2), 2000, pp. 153-165

Authors: Skott, P Achour, A Norin, M Thorstensson, R Bjorling, E
Citation: P. Skott et al., Characterization of neutralizing sites in the second variable and fourth variable region in gp125 and a conserved region in gp36 of human immunodeficiency virus type 2, VIRAL IMMUN, 12(1), 1999, pp. 79-88

Authors: Morner, A Achour, A Norin, M Thorstensson, R Bjorling, E
Citation: A. Morner et al., Fine characterization of a V3-region neutralizing epitope in human immunodeficiency virus type 2, VIRUS RES, 59(1), 1999, pp. 49-60

Authors: Andersson, S Thorstensson, R Ramirez, KG Krook, A von Sydow, M Dias, F Biberfeld, G
Citation: S. Andersson et al., Comparative evaluation of 14 immunoassays for detection of antibodies to the human T-lymphotropic virus types I and II using panels of sera from Sweden and West Africa, TRANSFUSION, 39(8), 1999, pp. 845-851

Authors: Morner, A Bjorndal, A Albert, J Kewalramani, VN Littman, DR Inoue, R Thorstensson, R Fenyo, EM Bjorling, E
Citation: A. Morner et al., Primary human immunodeficiency virus type 2 (HIV-2) isolates, like HIV-1 isolates, frequently use CCR5 but show promiscuity in coreceptor usage, J VIROLOGY, 73(3), 1999, pp. 2343-2349

Authors: Ahmed, RKS Nilsson, C Wang, YF Lehner, T Biberfeld, G Thorstensson, R
Citation: Rks. Ahmed et al., beta-chemokine production in macaques vaccinated with live attenuated virus correlates with protection against simian immunodeficiency virus (SIVsm) challenge, J GEN VIROL, 80, 1999, pp. 1569-1574
Risultati: 1-11 |